Clearmind Medicine Raises $3.5 Million
Synthetic psychedelic medicine company Clearmind Medicine Inc. (Nasdaq: CMND) (CSE: CMND) closed on a public offering on April 6 to raise $3.5 million. Clearmind said it expects to use the net proceeds from the offering for general corporate purposes, which may include operating expenses, working capital, future acquisitions, research and development, including clinical and pre-clinical testing of its product candidates.
Read More from the Global Wellness News ™